Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
Dermata Therapeutics reported positive topline results from a 31-participant open-label cosmetic study of Tome Foundational Treatment, its once-weekly skin renewal product. Per the release, 93% of participants agreed Tome was comparable to a professional in-office procedure and 90% saw more noticeable results than other products, with no treatment-related adverse events.
Key figures
- Drug Name
- Tome Foundational Treatment
- Phase Of Trial
- open-label cosmetic study
- Participants
- 31
- Pct more noticeable results
- 90%
- Treatment related adverse events
- 0
- Pct comparable to professional procedure
- 93%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.